75
Participants
Start Date
April 30, 2012
Primary Completion Date
October 31, 2017
Study Completion Date
October 31, 2017
Visipaque 320 and SonoVue
"Intervention is related to the administration of contrast agents:~Iodixanol, 320 mg of iodine per millilitre, Visipaque 320 (GE Healthcare, Milwaukee, WI, USA) for contrast-enahnced CTA, Sodium hexafluoride (SonoVue, Bracco Imaging, Milan, Italy) for CEUS"
Enrico Ammirati
OTHER